Redeye Feed

2026-05-28 18:37:00 AcouSort (Q1 Review): Reduced financing concerns and further validation points

2026-05-28 18:36:00 Saniona (Q1 Review): Setting up for the long run

2026-05-28 18:35:00 FluoGuide (Q1 Review): Catalyst-Heavy Remainder of 2026

2026-05-28 18:34:00 SynAct (Q1 Update): ADVANCE Topline in June

2026-05-27 11:44:00 Gentoo Media (Q1 Review): Maintaining strong cost control

2026-05-26 12:19:00 OncoZenge (Q1 Review): Final CTA approval received, initiating pivotal study

2026-05-26 11:49:00 Better Collective (Q1 Review): Heading into high season

2026-05-26 11:48:00 Goodbye Kansas Group (Q1 Review): Profitability in focus

2026-05-26 11:47:00 Embracer (Q4 Review): Strong Q4; Fellowship spin-off to crystallize value of AAA portfolio

2026-05-26 11:45:00 Nanologica (Q1 review): Harvesting season ahead?

2026-05-21 15:24:00 Vertiseit: Back to the roots

2026-05-21 13:51:00 GomSpace (Q1 Interview): Key Highlights, Strategic Direction and Outlook

2026-05-21 13:45:00 Lagercrantz (Q4 review): Progress towards the 20% margin target

2026-05-21 12:08:00 Better Collective (Q1 Initial take): Q1 largely as expected and full year guidance reiterated

2026-05-21 12:07:00 Paxman (Q1 Initial take): In line with expectations

2026-05-21 12:06:00 Gentoo Media (Q1 Initial take): Results in line, cost savings supported solid EBITDA-margin

2026-05-21 12:05:00 GiG Software (Q1 Initial take): Soft EBITDA, but topline as expected and guidance reiterated

2026-05-21 12:04:00 Xplora (Q1 Initial take): Power first major retail launch

2026-05-21 11:58:00 Surgical Science (Q1 Review): First steps to regain confidence

2026-05-21 11:57:00 Cantargia (Q1 Review): Shift Towards RAS Combination Strategy

2026-05-21 11:55:00 AAC Clyde Space (Q1 Review): Resuming the Growth Trajectory

2026-05-20 11:21:00 Oncopeptides (Q1 Update): Strong Quarterly Growth and Decreased Costs

2026-05-20 11:20:00 Neola Medical (Q1 Review): An undramatic report after an eventful period

2026-05-19 13:14:00 Isofol Medical (Q1 Review): Tailwind despite slower recruitment

2026-05-19 11:17:00 Redeye initiates coverage of 4C Group

2026-05-19 11:14:00 Sprint Bioscience (Q1 Review): Momentum in the business

2026-05-19 11:12:00 Acarix (Q1 Review): Continued US traction and improved cost base

2026-05-19 11:11:00 Smart Eye (Q1 Review): The Lights Go Out and Away We Go

2026-05-18 12:16:00 IDL Diagnostics (Q1 Review): Strong start to 2026

2026-05-18 12:15:00 Fable Media Group (Q1 Review): One Hand on the Trophy

2026-05-18 12:14:00 Oncopeptides (Q1 Update): Strong Quarterly Growth and Decreased Costs

2026-05-18 12:13:00 Nekkar (Q1 Review): In the Midst of Tender Season

2026-05-18 12:12:00 Siljansvik (Q1 Review): Strong operational momentum and increasing structural optionality

2026-05-18 12:11:00 Relais (Q1 review): Top-line beat driven by winter tailwinds

2026-05-13 15:18:00 Alzinova (Q1 Review): Scientific validation and strategic optionality

2026-05-13 14:47:00 Camurus (Q1 review): Revenues Below Expectations, but Robust Patient Growth

2026-05-13 14:46:00 Cinclus Pharma (Q1 Review): Strengthened finances enables a seamless transition

2026-05-13 14:43:00 Ascelia Pharma (Q1 review): PDUFA-date closing in

2026-05-13 12:09:00 Better Collective (Q1 Preview): Return to organic growth, albeit tempered by sportswin margin headwind

2026-05-13 12:03:00 Redeye initiates coverage of InCoax Networks

2026-05-13 12:01:00 Transtema (Q1 Review): Progress in negotiations

2026-05-13 11:59:00 SciBase (Q1 Review): Progress across key growth drivers

2026-05-13 11:58:00 Coffee Stain Group (Q4 Review): Leaner blend, stronger brew

2026-05-13 11:57:00 CLS (Q1 Review): Well aligned with our expectations

2026-05-13 11:56:00 Moberg Pharma (Q1 Review): APAC Expansion strengthens long-term growth case

2026-05-12 11:47:00 Paxman (Q1 Preview): First CPT1 quarter

2026-05-12 11:43:00 CTEK (Q1 Review): Margin strength and strategic refocus

2026-05-12 11:42:00 W5 Solutions (Q1 Review): Solid order intake derisks growth forecasts

↑	Select newer press release
↓	Select older press release
←	Navigate backwards
→	Navigate forward
Enter	Navigate to line in focus
Tab	Focus next link
A or 1	Open First attachment
S or 2	Open Second attachment
D or 3	Open Third attachment
F or 4	Open Fourth attachment
I	Show company information
PgUp	Select newest press release
PgDown	Select oldest press release
L	Focus on filer bar
N	Increase preview window size
M	Decrease preview window size
Esc	Escape from mode

Redeye

Prenumeration

Vem äger bolaget?

Redeye

Prenumeration

Vem äger bolaget?

Språk

Typ

År

Språk

Typ

Ett mail har skickats till den givna adressen. För att logga in, klicka på "Login" i mailet för att verifiera ditt konto

Företag

Pressmeddelanden